 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/03/2025 |
$1.53 |
$1.53 |
$1.45 |
$1.47 |
773.70K | | 11/04/2025 |
$1.42 |
$1.50 |
$1.40 |
$1.41 |
607.20K | | 11/05/2025 |
$1.43 |
$1.44 |
$1.40 |
$1.43 |
475.30K | | 11/06/2025 |
$1.42 |
$1.53 |
$1.41 |
$1.47 |
759.80K | | 11/07/2025 |
$1.41 |
$1.50 |
$1.39 |
$1.47 |
1.20M |
 |
| Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. It has developed two versatile and enabling platform technologies for rational design of precision immune modulatory drugs. Its lead clinical candidates, APVO436 and ALG.APV-527, and preclinical candidates, APVO603 and APVO711, are developed using its ADAPTIR modular protein technology platform. Its preclinical candidate APVO442 is developed using its ADAPTIR-FLEX modular protein technology platform. | |
 |

Aptevo Therapeutics (APVO) has the following price history information. Looking back at APVO historical stock prices for the last five trading days, on November 03, 2025, APVO opened at $1.53, traded as high as $1.53 and as low as $1.45, and closed at $1.47. Trading volume was a total of 773.70K shares. On November 04, 2025, APVO opened at $1.42, traded as high as $1.50 and as low as $1.40, and closed at $1.41. Trading volume was a total of 607.20K shares. On November 05, 2025, APVO opened at $1.43, traded as high as $1.44 and as low as $1.40, and closed at $1.43. Trading volume was a total of 475.30K shares. On November 06, 2025, APVO opened at $1.42, traded as high as $1.53 and as low as $1.41, and closed at $1.47. Trading volume was a total of 759.80K shares. On November 07, 2025, APVO opened at $1.41, traded as high as $1.50 and as low as $1.39, and closed at $1.47. Trading volume was a total of 1.20M shares.
APVO Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aptevo Therapeutics shares, starting with a $10,000 purchase of APVO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/21/2016 |
|
| End date: |
11/07/2025 |
|
| Start price/share: |
$3,646,720.00 |
|
| End price/share: |
$1.47 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-100.00% |
|
| Average Annual Total Return: |
-79.45% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$0.00 |
|
| Years: |
9.30 |
|
|
 |
| Date |
Close |
| 11/03/2025 | $1.47 | | 11/04/2025 | $1.41 | | 11/05/2025 | $1.43 | | 11/06/2025 | $1.47 | | 11/07/2025 | $1.47 |
|
 |